Cell and Gene Therapy (CGT) pioneers require supply chain partnerships that deliver experience in mitigating trial risk and complexity, along with a consultative approach to protocol execution. In this presentation, we’ll explore how integrated response technologies can be leveraged to:
- Optimize pre-trial and pre-screening activities for greater trial efficiency
- Overcome logistical challenges and ensure quality in the management of CGT trials
- Reduce trial costs and support sustainable CGT success
Introducing IMMUSE®, an award-winning and innovative postbiotic for immune health. This well-researched and effective ingredient will empower beverage manufacturers to elevate their functional drinks that resonates with health-conscious consumers. By incorporating IMMUSE®, you not only boost your product’s immune-supporting benefits but also align with the latest trends in wellness and innovation. Learn how IMMUSE® can be seamlessly integrated into your beverage formulations, providing a competitive edge and meeting the growing demand for functional, health-promoting drinks.